| pubmed-article:18389220 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18389220 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18389220 | lifeskim:mentions | umls-concept:C0012265 | lld:lifeskim |
| pubmed-article:18389220 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:18389220 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:18389220 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:18389220 | lifeskim:mentions | umls-concept:C0332157 | lld:lifeskim |
| pubmed-article:18389220 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:18389220 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
| pubmed-article:18389220 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
| pubmed-article:18389220 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:18389220 | pubmed:dateCreated | 2008-7-28 | lld:pubmed |
| pubmed-article:18389220 | pubmed:abstractText | To evaluate the use of antidotal therapy in patients with an elevated digitalis concentration following chronic or acute exposure. | lld:pubmed |
| pubmed-article:18389220 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18389220 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18389220 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18389220 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18389220 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18389220 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18389220 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18389220 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18389220 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18389220 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:18389220 | pubmed:issn | 0342-4642 | lld:pubmed |
| pubmed-article:18389220 | pubmed:author | pubmed-author:BorronStephen... | lld:pubmed |
| pubmed-article:18389220 | pubmed:author | pubmed-author:MégarbaneBrun... | lld:pubmed |
| pubmed-article:18389220 | pubmed:author | pubmed-author:AdnetFrédéric... | lld:pubmed |
| pubmed-article:18389220 | pubmed:author | pubmed-author:LapostolleFré... | lld:pubmed |
| pubmed-article:18389220 | pubmed:author | pubmed-author:BaudFrédéricF | lld:pubmed |
| pubmed-article:18389220 | pubmed:author | pubmed-author:VerdierCarine... | lld:pubmed |
| pubmed-article:18389220 | pubmed:author | pubmed-author:ArnaudFabrice... | lld:pubmed |
| pubmed-article:18389220 | pubmed:author | pubmed-author:CouvreurJames... | lld:pubmed |
| pubmed-article:18389220 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18389220 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:18389220 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18389220 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18389220 | pubmed:pagination | 1448-53 | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:meshHeading | pubmed-meshheading:18389220... | lld:pubmed |
| pubmed-article:18389220 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18389220 | pubmed:articleTitle | Assessment of digoxin antibody use in patients with elevated serum digoxin following chronic or acute exposure. | lld:pubmed |
| pubmed-article:18389220 | pubmed:affiliation | Hôpital Avicenne, Bobigny, France. frederic.lapostolle@avc.ap-hop-paris.fr | lld:pubmed |
| pubmed-article:18389220 | pubmed:publicationType | Journal Article | lld:pubmed |
